Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
Kedudukan dalam Saham #28327
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Harga Saham
$1.11
Modal Pasaran
$27.17M
Perubahan (1 hari)
0.19%
Perubahan (1 tahun)
58.22%
Negara
KR
Perdagangan Dong Sung Bio Pharm.Co.,Ltd. (002210)

Kategori

Hasil untuk Dong Sung Bio Pharm.Co.,Ltd. (002210)
Hasil pada Mar 2026 TTM: $55.28M
Menurut laporan kewangan terkini daripada Dong Sung Bio Pharm.Co.,Ltd., hasil semasa syarikat (TTM) ialah $55.28M. Pada tahun 2023, syarikat memperoleh hasil sebanyak $68.44M penurunan berbanding hasil pada tahun 2022 iaitu $73.96M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Dong Sung Bio Pharm.Co.,Ltd. dari 2007 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $55.28M -8.11%
2024 $60.16M -12.09%
2023 $68.44M -7.47%
2022 $73.96M 4.17%
2021 $71.00M -12.21%
2020 $80.87M 7.92%
2019 $74.94M -9.21%
2018 $82.54M 6.78%
2017 $77.30M 16.92%
2016 $66.12M 4.07%
2015 $63.53M -4.97%
2014 $66.85M -6.37%
2013 $71.41M -10.13%
2012 $79.45M 17.40%
2011 $67.68M 5.52%
2010 $64.14M 8.31%
2009 $59.22M 22.81%
2008 $48.22M -25.17%
2007 $64.44M 0.00%
Hasil untuk syarikat atau pesaing serupa